AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance ...

Since 2023, AstraZeneca has invested more than USD1.7 billion to expand its production in China, including spending USD750 million to build a new inhaler production base in Qingdao, eastern Shandong ...

AstraZeneca's five-year US$2.5 billion investment, announced on Friday, includes a new research-and-development center in Beijing and a research agreement with Harbour BioMed. The U.K. firm will also ...

We will probably not have any clarification on how the reciprocal tariffs will play out until April 2 — provided Trump isn’t ...

The death toll in Gaza has passed the 50,000 mark as Israel expanded its fighting in the Palestinian enclave on Sunday.

Major news from Europe included earnings and investment updates. AstraZeneca ( AZN) is expanding its footprint in China with an investment of $2.5B in Beijing over the next five years to build its ...

Chinese Premier Li Qiang urged nations to open markets to combat global instability at the China Development Forum. He met ...

Chinese Premier Li Qiang urged countries to open up their markets to combat "rising instability and uncertainty" at a ...

The document outlines various health-related news, including a measles outbreak in Texas and New Mexico, UNICEF's aid crisis ...

The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...

AstraZeneca said on Friday it will spend Ksh.323 billion on a research and development hub in Beijing, as the drugmaker ...

In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment in Beijing over the next five years. The pharmaceutical titan ...